advertisement

Topcon

Sadlak N 9

Showing records 1 to 9 | Display all abstracts from Sadlak N

95352 A Comparison of Patient Acceptance of 3 Eye Drop Instillation Aids
Zhu CQ
Journal of Glaucoma 2021; 30: 725-731
94894 Real-World Clinical Impact of Netarsudil 0.02% at an Urban Safety-Net Hospital
Fridman G; Sadlak N
Journal of Ocular Pharmacology and Therapeutics 2021; 37: 338-342
95352 A Comparison of Patient Acceptance of 3 Eye Drop Instillation Aids
Sadlak N; Sadlak N
Journal of Glaucoma 2021; 30: 725-731
94894 Real-World Clinical Impact of Netarsudil 0.02% at an Urban Safety-Net Hospital
Sadlak N
Journal of Ocular Pharmacology and Therapeutics 2021; 37: 338-342
95352 A Comparison of Patient Acceptance of 3 Eye Drop Instillation Aids
Fiorello MG
Journal of Glaucoma 2021; 30: 725-731
94894 Real-World Clinical Impact of Netarsudil 0.02% at an Urban Safety-Net Hospital
Eliassi-Rad B
Journal of Ocular Pharmacology and Therapeutics 2021; 37: 338-342
95352 A Comparison of Patient Acceptance of 3 Eye Drop Instillation Aids
Lee D
Journal of Glaucoma 2021; 30: 725-731
94894 Real-World Clinical Impact of Netarsudil 0.02% at an Urban Safety-Net Hospital
Desai MA
Journal of Ocular Pharmacology and Therapeutics 2021; 37: 338-342
95352 A Comparison of Patient Acceptance of 3 Eye Drop Instillation Aids
Desai M
Journal of Glaucoma 2021; 30: 725-731

Issue 22-2

Change Issue


advertisement

Oculus